Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: For human use
Package code: 1783144
Name of medicinal product: TAKHZYRO
Active substances:
Lanadelumab
Estonian, English, Latin
ATC code: B06AC05
Dosage form: solution for injection
Route of administration: subcutaneous use
Strengh: 300mg 2ml
Amount in package: 2ml 1TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: TAKHZYRO is indicated for routine prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 2 years and older.
Safety features: Yes
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Labelling:  
Last imported to Estonia: Never imported to Estonia
Marketing authorization holder: Takeda Pharmaceuticals International AG Ireland Branch 
Marketing authorization number: EU/1/18/1340 
Marketing authorization issued on: November 22, 2018 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Reference price:   
Under reference price:   
Reference price of daily dose:   
Entry/Changing date: November 24, 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere